Decision Aids Upper and Lower Extremity

March 6, 2019 updated by: David Ring, University of Texas at Austin

A Randomized Controlled Trial of Decision Aids for Upper and Lower Extremity Conditions.

This study aims to assess differences in choice of treatment (and the rationale behind it), physical function, pain intensity, satisfaction, and decision regret between orthopedic patients who review a decision aid during their visit and those that do not. Decision aids for 23 different conditions are included.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Patients visiting an orthopeadic surgeon in one of our 4 affiliated offices in a large urban area in the United States are invited to participate over a 4 month period. All English-speaking patients, between 18 and 89 years old, visiting an orthopeadic surgeon with a new problem, for which either invasive or non-invasive treatment is possible and a DA is available are asked to participate in this study. Exclusion criteria are non-English speakers or a clear preference for a treatment option by surgeon or patient. Patients will be randomly assigned to either the intervention or the control group in a 1:1 ratio using an Excel random number generator. Patients in the intervention group go over the DA during the visit, once the surgeon has identified the diagnosis. After the diagnosis is set, the surgeon steps out of the visit and steps back in when the patients has reviewed the DA. The surgeon and the patient go over the treatment options and a decision will be made. After the visit, all patients, both in the intervention and control group, are asked to fill out a survey. Two weeks after enrollment a research assistant calls all patients for a follow up questionnaire.

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Austin, Texas, United States, 78705
        • Austin Regional Clinic
      • Austin, Texas, United States, 78712
        • HTB Musculoskeletal Institute
      • Austin, Texas, United States, 78751
        • Orthopedic Specialists of Austin
      • Austin, Texas, United States, 78705
        • Texas Orthopedics
      • Austin, Texas, United States, 78731
        • Seton Institute for Plastic and Reconstructive Surgery
      • Austin, Texas, United States, 78756
        • ATX Ortho

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

English-speaking, adult patients seeing an upper or lower extremity surgeon for a new visit regarding diagnoses that can be treated invasively and non-invasively:

Shoulder

  • Clavicle fracture in the middle
  • Clavicle fracture close to the shoulder
  • Proximal humerus fracture
  • Humerus shaft fracture
  • Distal humerus fracture

Elbow

  • Lateral epicondylitis
  • Ruptured biceps at the elbow
  • Olecranon fracture
  • Radial head fracture
  • Olecranon bursitis

Hand/wrist

  • Distal radius fracture
  • Carpal tunnel syndrome
  • Scaphoid fracture
  • Thumb arthrosis
  • Trigger finger
  • Mallet fracture
  • de Quervain tendinopathy
  • Wrist ganglion
  • Dupuytren

Knee • Knee arthritis: cortisone injection

Hip

• Hip arthritis: total hip arthroplasty

Exclusion Criteria:

  • Obvious indication for one treatment approach, either from the surgeon or the patient perspective.
  • Patients who do not want to be contacted for follow-up.
  • Non-English speaking patients, because the decision aids used in this study are not currently validated to non-English language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Decision Aid Group
These patients review a decision aid.
The decision aids aim to inform the patients about the diagnosis and the treatment options. They aim to help the patient prioritize and make an informed decision.
No Intervention: Control Group
These patients do not review a decision aid.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction on a 11-point ordinal scale
Time Frame: From enrollment till follow-up after two weeks
On a scale of 0-10 how satisfied were you with this visit 0 being totally dissatisfied and 10 being totally satisfied.
From enrollment till follow-up after two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcomes Measurement Information System Physical Function Computer Adaptive Test (directly after visit)
Time Frame: From enrollment till two weeks after visit

Questionnaire that measures patients self-reported capability of physical activities.

This Questionnaire is a CAT: Computerized Adaptive Test. Participant responses guide the system's choice of subsequent items from the full item bank (121 items in total in adult bank). Although items differ across respondents taking CAT, scores are comparable across participants.

CAT will continue until either the standard error drops below a specified level, or the participant has answered the maximum number of questions (12), whichever occurs first.

A score of 50 is the average for the United States general population with a standard deviation of 10 because calibration testing was performed on a large sample of the general population. Range scores 19-76. Higher scores is better physical function.

From enrollment till two weeks after visit
Pain intensity on an 11-point ordinal scale
Time Frame: From enrollment till two weeks after visit
Can you rate your pain on a scale of 0-10, 0 meaning no pain and 10 meaning the worst possible pain.
From enrollment till two weeks after visit
Decision regret scale (O'Connor '96)
Time Frame: One time measurement, two weeks after the visit.

Measures 'distress' or 'remorse' after a (health care) decision. Scale from 1-5, 1 being strongly agree, 5 being stongly disagree

  1. it was the right decision
  2. I regret the choice that was made
  3. I would go for the same chice if I had to do it over again
  4. The choice did me a lot of harm
  5. The decision was a wise one
One time measurement, two weeks after the visit.
Choice of treatment (invasive/non-invasive)
Time Frame: Day of enrollment
Patients have to fill out if they either chose invasive treatment (surgery) or non-invasive treatment (no surgery)
Day of enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Actual)

February 1, 2019

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

August 18, 2018

First Submitted That Met QC Criteria

August 21, 2018

First Posted (Actual)

August 23, 2018

Study Record Updates

Last Update Posted (Actual)

March 8, 2019

Last Update Submitted That Met QC Criteria

March 6, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2018-07-0027

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Extremity Dysfunction

Clinical Trials on Decision aid

Subscribe